Speaker(s): 

Samuel Slimmer, MD, Staff Member, Geisinger - has nothing to disclose.

Mark Olaf, DO, Staff Member, Geisinger - has nothing to disclose.

Eric Melnychuk, DO, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss the various brady dysrhythmias
• Discuss the electrocardiographic manifestations of cardiac conduction disorders
• Discuss the definition of multidrug resistant organisms
• Discuss specific MDRO and treatment strategies
• Review the characteristics of COPD
• Outline current effective treatments for COPD exacerbations
• Review hypercapnia and survival after hospitalization for COPD exacerbation
• Recognize common features and presenting symptoms of compensated and decompensated cirrhosis in the ED
• Recognize and manage complications of decompensated cirrhosis in the ED

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Mark Olaf, DO have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.